Ensho Therapeutics, Inc.

This early-stage study is testing a new drug, NSHO-101, in 24 healthy adults. The main goal is to see how the body handles the drug and whether it is safe. Participants must be in good health and willing to follow study rules. This research does not aim to treat any disease.